Expression analysis of 93 selected genes for prediction of treatment response in childhood acute lymphoblastic leukemia (ALL)
R Romey, M Stanulla, R Häsler, S Schreiber, M Zimmermann, M Schrappe, G Cario · Klinische Pädiatrie · 2009 · Heft 05
Bibliografische Angaben
Zusammenfassung
In trial ALL-BFM 2000, risk adapted treatment stratification is mainly based on the assessment of in-vivo response to treatment. However, to optimally adjust treatment, identification of resistant patients as early as possible would be desirable. In previous studies we and others showed that distinct gene expression profiles, measured in leukemic cells obtained prior treatment, can predict molecular treatment response and outcome. To validate these findings, we selected 93 genes, 54 from our and 39 from other published studies, and measured the expression of these genes based on qRT-PCR in two representative set…